000			01975 a2200577 4500
005			20250515172544.0
264		0	_c20090630
008			200906s 0 0 eng d
022			_a1533-3450
024	7		_a10.1681/ASN.2008101037 _2doi
040			_aNLM _beng _cNLM
100	1		_aNoël, Christian
245	0	0	_aDaclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. _h[electronic resource]
260			_bJournal of the American Society of Nephrology : JASN _cJun 2009
300			_a1385-92 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
650	0	4	_aAdult
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntilymphocyte Serum _xtherapeutic use
650	0	4	_aBiopsy
650	0	4	_aDaclizumab
650	0	4	_aFemale
650	0	4	_aGraft Rejection _xpathology
650	0	4	_aHumans
650	0	4	_aImmunoglobulin G _xtherapeutic use
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aKidney _xpathology
650	0	4	_aKidney Transplantation
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aProspective Studies
650	0	4	_aRisk Factors
650	0	4	_aTreatment Outcome
700	1		_aAbramowicz, Daniel
700	1		_aDurand, Dominique
700	1		_aMourad, Georges
700	1		_aLang, Philippe
700	1		_aKessler, Michèle
700	1		_aCharpentier, Bernard
700	1		_aTouchard, Guy
700	1		_aBerthoux, François
700	1		_aMerville, Pierre
700	1		_aOuali, Nacera
700	1		_aSquifflet, Jean-Paul
700	1		_aBayle, François
700	1		_aWissing, Karl Martin
700	1		_aHazzan, Marc
773	0		_tJournal of the American Society of Nephrology : JASN _gvol. 20 _gno. 6 _gp. 1385-92
856	4	0	_uhttps://doi.org/10.1681/ASN.2008101037 _zAvailable from publisher's website
999			_c18896373 _d18896373